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Abstract
Random-effects meta-analyses have been widely applied in evidence synthesis
for various types of medical studies. However, standard inference methods (e.g.
restricted maximum likelihood estimation) usually underestimate statistical er-
rors and possibly provide highly overconfident results under realistic situations;
for instance, coverage probabilities of confidence intervals can be substantially
below the nominal level. The main reason is that these inference methods rely
on large sample approximations even though the number of synthesized studies
is usually small or moderate in practice. In this article we solve this problem
using a unified inference method based on Monte Carlo conditioning for broad
application to random-effects meta-analysis. The developed method provides
improved confidence intervals with coverage probabilities that are closer to the
nominal level than standard methods. As specific applications, we provide new
inference procedures for three types of meta-analysis: conventional univariate
meta-analysis for pairwise treatment comparisons, meta-analysis of diagnostic
test accuracy, and multiple treatment comparisons via network meta-analysis.
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We also illustrate the practical effectiveness of these methods via real data appli-
cations and simulation studies. Confidence interval; Meta-analysis; Likelihood
ratio test; Random-effects model
1 Introduction
In evidence-based medicine, meta-analysis has been an essential tool for quantitatively
summarizing multiple studies and producing integrated evidence. In general, the
treatment effects from different sources of evidence are heterogeneous due to various
factors, which should be adequately addressed, otherwise statistical errors may be
seriously underestimated and possibly result in misleading conclusions (Higgins and
Green, 2011). Such heterogeneity can be generally divided into two types, fixed-effects
and random-effects, and the comparison between two methods have been discussed
(e.g. Hedges and Vevea, 1998; Overton, 1998). As noted in Rice and others (2018),
fixed-effects and random-effects methods are respectively validated under different
settings and assumptions. On the other hand, random-effects models are widely used
in most medical meta-analyses. The applications cover various types of systematic
reviews, for example, conventional univariate meta-analysis (DerSimonian and Laird,
1986; Whitehead and Whitehead, 1991), meta-analysis of diagnostic test accuracy
(Reitsma and others, 2005), network meta-analysis for comparing the effectiveness of
multiple treatments (Salanti, 2012), and individual participant meta-analysis (Riley
and others, 2010). In view of this background, we focused on random-effects meta-
analysis in this paper.
However, in random-effects meta-analysis, most existing standard inference meth-
ods (e.g. restricted maximum likelihood method) for average treatment effect pa-
rameters underestimate statistical errors under realistic situations of medical meta-
analysis. For example, the coverage probabilities of standard inference methods are
usually smaller than the nominal confidence levels, even when the model is completely
specified (Brockwell and Gordon, 2001), which may lead to highly overconfident con-
clusions. This notable problem is related to heterogeneity variance-covariance param-
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eters, typically treated as nuisance parameters, included in random-effects models.
When the number of studies is small, estimators (e.g. restricted maximum likelihood
estimator) of such variance parameters have high variability, so that they tend to
underestimate the true value and sometimes produce an exact estimate of 0. In the
standard inference methods, such variability is often ignored using large sample ap-
proximations for the number of studies whereas the number is small or moderate in
medical meta-analysis, which results that the total statistical error can be underes-
timated when constructing confidence intervals. So far, several confidence intervals
that aim to improve the undercoverage property have been developed, for example,
by Hartung and Knapp (2001), Hartung and Knapp (2001), Henmi and Copas (2010),
Jackson and Bowden (2009), Jackson and Riley (2014), Knapp and Hartung (2003),
Noma (2011), Noma and others (2018), Guolo (2012), Sanchez-Meca and Marin-
Martinez (2008) and Sidik and Jonkman (2002). Although these methods improve
coverage properties, they are substantially valid under the large number of samples.
Moreover, most of these methods were developed in the context of traditional direct
pairwise comparisons; therefore, the methods have limited applicability in recent,
more advanced types of meta-analysis that use the complicated multivariate models.
In this paper, we develop a unified method for constructing confidence intervals
(regions) for parameters in random-effects models so that their coverage probabili-
ties are almost equal to the nominal level regardless of the number of studies. To
effectively circumvent the effects of nuisance parameters, we consider the likelihood
ratio test (LRT) for the average treatment effect, and we define its p-value based
on the conditional distribution given the maximum likelihood estimator of the nui-
sance parameters rather than the unconditional distribution of the test statistic. For
computing the p-value, we adopt the Monte Carlo conditioning technique proposed
by Lindqvist and Taraldsen (2005), and the confidence interval can be derived by
inverting the LRT. As a result, the derived confidence intervals are shown to have
reasonable coverage probabilities and the proposed method can be generally applied
to various types of meta-analysis involving complicated multivariate random-effects
models.
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This paper is organized as follows. In Section 2, we first provide an algorithm
for computing the p-value of the LRT and derive confidence intervals under general
statistical models. In Sections 3, 4 and 5, we demonstrate the proposed method in
univariate meta-analysis for direct pairwise comparisons, bivariate meta-analysis for
diagnostic test accuracy and network meta-analysis, respectively, using real datasets
and simulations. Discussion is provided in Section 6.
2 Algorithm for confidence interval
We suppose y1, . . . , yk are independent and each has the density or probability mass
function fi(yi;φ, ψ) with parameter of interest φ and nuisance parameter ψ. For ex-
ample, in the univariate meta-analysis described in Section 3, k and yi correspond
to the number of studies and estimated treatment effect in the ith study, respec-
tively, and we use the model yi ∼ N(µ, τ2 + σ2i ) with known σ2i to estimate the
average treatment effect µ, so that φ = µ and ψ = τ2 in this case. In general, yi,
φ and ψ could be multivariate, but we assume in this section that all of them are
one-dimensional in order to make our presentation simpler. Multivariate cases are
considered in Sections 4 and 5. The likelihood ratio test (LRT) statistic for testing
null hypothesis H0 : φ = φ0 is Tφ0(Y ) = −2 {maxψ L(Y, φ0, ψ)−maxφ,ψ L(Y, φ, ψ)},
where Y = (y1, . . . , yk)
t, and L(Y, φ, ψ) =
∑k
i=1 log fi(yi;φ, ψ) is the log-likelihood
function. Under some regularity conditions, the asymptotic distribution of Tφ0(Y )
under H0 is χ
2(1) as k → ∞. However, when the sample size k is not large as is
often the case in meta-analysis, the approximation is not accurate enough. The main
reason is that there is an unknown nuisance parameter ψ and its estimation error is
not ignorable when k is not large. To overcome this problem, we calculate the p-value
of the statistic Tφ0(Y ) based on the conditional distribution Y |ψ̂(φ0), where ψ̂(φ0)
is the maximum likelihood estimator of ψ under H0. For computing the p-value, we
adopt the Monte Carlo conditioning developed in Lindqvist and Taraldsen (2005).
To describe the general methodology, we further assume that Y can be expressed
as Y = H(U, φ, ψ) for some function H and random variable U whose distribution
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is completely known. For example, when Y ∼ N(φ, ψ), it holds that Y = φ +√ψU
with U ∼ N(0, 1). Now, the maximum likelihood estimator ψ̂ under H0 satisfies
the equation, Lψ(Y, φ0, ψ̂) = 0, where Lψ = ∂L/∂ψ is the partial derivative of the
likelihood function L with respect to the nuisance parameter ψ. Under H0, Y can be
expressed as Y = H(U, φ0, ψ); thereby, the above equation can be rewritten as
δ(U, ψ̂, ψ) ≡ Lψ(H(U, φ0, ψ), φ0, ψ̂) = 0.
We define ψ∗(U) as the solution of the above equation with respect to ψ. Using
the result in Lindqvist and Taraldsen (2005), the p-value E
[
I{T (Y ) ≥ t}|ψ̂] can be
expressed as
E
[
I{T (Y ) ≥ t}|ψ̂] = E[I{T (H(U, φ0, ψ∗(U))) ≥ t}w(U)]
E
[
w(U)
] , (1)
where the expectation is taken with respect to the distribution of U , and
w(U) =
∣∣∣∣∣ pi(ψ)∂ψ̂/∂ψ
∣∣∣∣∣
ψ=ψ∗(U)
(2)
with some function pi(ψ) of ψ. As noted in Lindqvist and Taraldsen (2005), the choice
of pi(ψ) controls the efficiency of the Monte Carlo approximation in (1). However,
the detailed discussion of this issue would extend of the scope of this paper; thus, we
consider in this paper only pi(ψ) = 1. The algorithm for computing the p-value for
testing H0 : φ = φ0 is given as follows.
Algorithm 1. (Monte Carlo method for p-value of LRT)
1. For b = 1, . . . , B with large B, generate a random sample, U (b) = (u
(b)
1 , . . . , u
(b)
k ),
and compute ψ∗(U (b)), Y
(b)
∗ = H(U (b), φ0, ψ∗(U (b))) and w(U (b)) from (2).
2. The Monte Carlo approximation of the p-value is given by
∑B
b=1 I
{
Tφ0(Y
(b)
∗ ) ≥ Tφ0(Y )
}
w(U (b))∑B
b=1w(U
(b))
.
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Using the p-value of the LRT of H0 : φ = φ0, the confidence interval of φ with
nominal level 1 − α can be constructed as the set of φ† such that the p-value of
the LRT of H0 : φ = φ
† is larger than α. Although the confidence limits cannot
be expressed in closed form, they can be computed by simple numerical methods,
for example the bisectional method that repeatedly bisects an interval and selects a
subinterval in which a root exists until the process converges numerically, see Section
2 in Burden and Faires (2010). When ψ is multivariate (vector-valued) parameters,
which is typical in many applications, the absolute value symbol in the weight (2)
should be recognized as the absolute value of determinant since ∂ψ̂/∂ψt is a matrix.
On the other hand, when φ is multivariate, we need to construct a confidence region
(CR) rather than a confidence interval. In this case, the bisectional method cannot
be directly applied, and methods for CRs would depend on each setting. In Section
4, we present a diagnostic meta-analysis in which a CR is traditionally used, and
provide a feasible algorithm to compute a CR.
3 Univariate random-effects meta-analysis
3.1 The random-effects model
The univariate random-effects model has been widely used in meta-analysis due to
its parametric simplicity. However, the accuracy of the inference is poor when the
number of studies is small. We consider solving this problem using the LRT and
confidence interval introduced in Section 2. We assume that there are k clinical trials
and that y1, . . . , yk are the estimated treatment effects. We consider the random-effect
model:
yi = θi + ei, θi = µ+ εi, i = 1, . . . , k, (3)
where θi is the true effect size of the ith study, and µ is the average treatment effect.
Here ei and εi are independent error terms within and across studies, respectively,
assumed to be distributed as ei ∼ N(0, σ2i ) and εi ∼ N(0, τ2). The within-studies
variances σ2i s are usually assumed to be known and fixed to their valid estimates cal-
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culated from each study. On the other hand, the across variance τ2 is an unknown pa-
rameter representing the heterogeneity between studies. Under these settings, Hardy
and Thompson (1996) considered the likelihood-based approach for estimating the
average treatment effect µ.
3.2 Confidence intervals of model parameters
We first consider a confidence interval of µ by using Algorithm 1 in the previous
section. To begin with, we consider the null hypothesis H0 : µ = µ0 with nuisance
parameter τ2. Since yi ∼ N(µ, τ2 + σ2i ) under the model (3), the LRT statistic can
be defined as Tµ0(Y ) = minµ,τ2 L(µ, τ
2)−minτ2 L(µ0, τ2), where
L(µ, τ2) =
k∑
i=1
log(τ2 + σ2i ) +
k∑
i=1
(yi − µ)2
τ2 + σ2i
. (4)
The minimization can be achieved in standard ways such as the iterative method in
Hardy and Thompson (1996).
From (4), the constrained maximum likelihood estimator τ̂2c of τ
2 under H0 sat-
isfies the following equation:
k∑
i=1
1
τ̂2c + σ
2
i
−
k∑
i=1
(yi − µ0)2
(τ̂2c + σ
2
i )
2
= 0.
Let u1, . . . , um be random variables that which independently follow N(0, 1), then yi
can be expressed as yi = µ0 + ui
√
τ2 + σ2i under H0. Substituting the expression for
yi in the above equation, we have
G(U, τ2, τ̂2c ) ≡
k∑
i=1
1
τ̂2c + σ
2
i
−
k∑
i=1
(τ2 + σ2i )u
2
i
(τ̂2c + σ
2
i )
2
= 0,
where U = (u, . . . , uk)
t. The above equation can be easily solved with respect to τ2
and the solution is given by
τ2∗ (U) =
{
k∑
i=1
u2i
(τ̂2c + σ
2
i )
2
}−1{ k∑
i=1
τ̂2c + σ
2
i (1− u2i )
(τ̂2c + σ
2
i )
2
}
.
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Regarding the weight (2), using the implicit function theorem for the equationG(U, τ2, τ̂2c ) =
0, it holds that
w(U) =
{
k∑
i=1
u2i
(τ̂2c + σ
2
i )
2
}−1 ∣∣∣∣∣
k∑
i=1
2{τ2∗ (U) + σ2i }u2i − (τ̂2c + σ2i )
(τ̂2c + σ
2
i )
3
∣∣∣∣∣ ,
and thereby we can compute the p-value of the LRT for H0 : µ = µ0 from Algorithm
1, and the confidence interval of µ by inverting the LRT.
A confidence interval of τ2 can be derived as well. By a similar derivation to that
for µ, the p-values of the LRT of H0 : τ
2 = τ20 can be computed from Algorithm 1
with w(U) = 1 and
µ∗(U) = µ̂−
(
k∑
i=1
1
τ20 + σ
2
i
)−1 k∑
i=1
ui√
τ20 + σ
2
i
,
so that the confidence interval of τ2 can be similarly constructed.
3.3 Simulation study
We evaluated the finite sample performance of the proposed confidence interval of
µ via Monte Carlo (MC) algorithm together with existing methods widely used in
practice. We considered the restricted maximum likelihood (REML) method, the
DerSimonian and Laird (DL) method (DerSimonian and Laird, 1986), the Knapp and
Hartung (KNHA) method (Knapp and Hartung, 2003) with random-effects variance
estimated by REML, and the likelihood ratio (LR) method (Hardy and Thompson,
1996). When implementing the proposed MC method, we used 1000 Monte Carlo
samples to compute the p-value. We fixed the true average treatment effect µ at−0.80,
and the heterogeneity variance τ2 at 0.10 and 0.20. We changed the number of studies
k over 3, 5, 7 and 9, and set the nominal level α to 0.05. To approximate practical
situations of medical meta-analyses, we followed the simulation settings considered
by Sidik and Jonkman (2007). We generated θi ∼ N(µ, τ2) and binomial data Xir ∼
Binomial(nir, pir) for i = 1, . . . , k and r = 0, 1 corresponding to control and treatment.
The response rate of control pi0 was generated from a continuous uniform distribution
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on [0.095, 0.65] and we set pi1 = pi0 exp(θi)/{1− pi0 + pi0 exp(θi)}, which means that
θi is odds ratio, i.e. θi = legit(pi1) − legit(pi0). The sample sizes were set to equal
ni1 = ni0 and were randomly sampled with replacement from the integers between 20
and 200. For the simulated binomial data, the summary statistics for θ1, . . . , θk, i.e.
sample log odds ratios yi and their estimated asymptotic variances s
2
i , are calculated.
Based on 2000 simulation runs, we calculated the coverage probabilities (CP) and
average lengths (AL) of the four confidence intervals.
The results, shown in Table 1, indicate that the confidence intervals from the three
methods, LR, REML and DL tend to be liberal to achieve the appropriate nominal
level 0.95 even when k = 9. On the other hand, the proposed MC method produces
reasonable confidence intervals with appropriate coverage probabilities even when k is
3. KNHA also provides reasonable confidence intervals even when k = 3, but overall
it tends to be slightly liberal compared with MC. The average lengths of MC and
KNHA are similar and longer than those of the other methods.
Table 1: Simulated coverage probabilities (%) and average lengths for 95% confidence
intervals from the proposed Monte Carlo (MC) method, the method by Knapp and
Hartung (2003), the likelihood ratio (LR) method, the restricted maximum likelihood
(REML) method, and the DerSimonian and Laird (DL) method.
Coverage Probability (%) Average Length
k 3 5 7 9 3 5 7 9
MC 96.6 96.1 96.4 95.3 2.032 1.146 0.861 0.710
KNHA 93.6 94.7 94.6 93.8 2.097 1.090 0.823 0.686
τ2 = 0.10 LR 92.8 93.7 93.5 92.6 1.233 0.884 0.725 0.626
REML 88.9 91.5 91.6 91.1 1.064 0.801 0.673 0.589
DL 89.2 91.8 92.0 90.8 1.068 0.801 0.673 0.590
MC 94.7 95.7 95.4 95.2 2.360 1.356 1.033 0.862
KNHA 93.5 94.4 94.9 94.5 2.482 1.310 1.005 0.843
τ2 = 0.20 LR 88.8 91.4 92.2 93.7 1.396 1.039 0.869 0.759
REML 83.9 89.2 90.3 92.1 1.207 0.941 0.805 0.715
DL 84.6 89.0 90.9 92.1 1.205 0.939 0.804 0.713
3.4 Example: treatment of suspected acute myocardial infarction
Here we applied the proposed method to a meta-analysis of the treatment of suspected
acute myocardial infarction with intravenous magnesium (Teo and others, 1991),
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which is well-known as it yielded conflicting results between meta-analyses and large
clinical trials (LeLorier and others, 1997). For the dataset, we constructed a 95%
confidence interval of the average treatment effect of intravenous magnesium using
the proposed MC method (with 10000 Monte Carlo samples) as well as the KNHA,
LR, REML and DL methods considered in the previous section. Moreover, we also
applied Peto’s fixed effect (PFE) method (Yusuf and others, 1995). The detailed
results are given in Supplementary Material. We found that the confidence intervals
from the KNHA, DL, LR, REML and PFE methods were narrower than that of
the MC method, and the confidence intervals from the five methods did not cover
µ = 1, which does not change the interpretation of the results. On the other hand, the
proposed MC method produced a longer confidence interval while also covering µ = 1,
that is, the corresponding test for µ = 1 was not significant with a 5% significant level.
4 Bivariate Meta-analysis of Diagnostic Test Accuracy
4.1 Bivariate random-effects model
There has been increasing interest in systematic reviews and meta-analyses of data
from diagnostic accuracy studies. For this purpose, a bivariate random-effect model
(Reitsma and others, 2005; Harbord and others, 2007) is widely used. Following
Reitsma and others (2005), we define µAi and µBi as the logit-transformed true
sensitivity and specificity, respectively, in the ith study. The bivariate model assumes
that (µAi, µBi)
t follows a bivariate normal distribution:
 µAi
µBi
 ∼ N

 µA
µB
 ,Σ
 with Σ =
 σ2A ρσAσB
ρσAσB σ
2
B
 , (5)
where µA and µB are the average logit-transformed sensitivity and specificity, and
σA(> 0) and σB(> 0) are standard deviations of µAi and µBi, respectively. Here the
parameter ρ ∈ (−1, 1) allows correlation between µAi and µBi. The unknown param-
eters are µA, µB, σ
2
A, σ
2
B and ρ. Let yAi and yBi be the observed logit-transformed
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sensitivity and specificity, and we assume that
 yAi
yBi
 ∼ N

 µAi
µBi
 , Ci
 with Ci =
 s2Ai 0
0 s2Bi
 . (6)
For summarizing the results of the meta-analysis, the CR of µ = (µA, µB)
t would
be more valuable than separate confidence intervals since sensitivity and specificity
might be highly correlated. Reitsma and others (2005) suggested the 100(1 − α)%
joint CR for µ as the interior points of the ellipse defined as
µA = µ̂A + cαŝA cos t, µB = µ̂B + cαŝB cos(t+ arccos ρ̂), t ∈ [0, 2pi), (7)
where µ̂A and µ̂B are estimates of µA and µB, ŝA and ŝB are estimated standard
errors of µ̂A and µ̂B, respectively, which are obtained via the restricted maximum
likelihood method. Here cα is the square root of the upper 100α% point of the χ
2
distribution with 2 degrees of freedom. The joint CR (7) is approximately valid;
specifically, the coverage error converges to 1− α as the number of studies k goes to
infinity. However, when k is not sufficiently large, the coverage error is not negligible,
and the region (7) would under-cover the true µ.
4.2 Confidence region of sensitivity and specificity
We consider a CR of µ under the models (5) and (6) based on the Monte Carlo
method given in Section 2. Let ψ = (σ2A, σ
2
B, ρ)
t be a vector of nuisance parameters,
and write Σ(ψ) rather than Σ to clarify the dependence of ψ. From (5) and (6), the
LRT statistic of the null hypothesis H0 : µ = µ0 is given by
Tµ0(Y ) = min
µ,ψ
L(µ, ψ)−min
ψ
L(µ0, ψ),
where
L(µ, ψ) =
k∑
i=1
log |Vi(ψ)|+
k∑
i=1
(yi − µ)tVi(ψ)−1(yi − µ),
with Vi(ψ) = Σ(ψ) + Ci.
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Under H0, the constrained maximum likelihood estimator ψ̂c satisfies the following
equations:
k∑
i=1
tr{Vi(ψ̂c)−1Jk} −
k∑
i=1
(yi − µ0)tVi(ψ̂c)−1JkVi(ψ̂c)−1(yi − µ) = 0, k = 1, 2, 3,
where
J1 =
 1 0
0 0
 , J2 =
 0 0
0 1
 , J3 =
 0 1
1 0
 .
Under H0, the observed data yi can be expressed as yi = µ0 + Ti(ψ)ui with ui ∼
N(0, I2) and Ti(ψ) being the Cholesky decomposition of Vi(ψ), that is, Ti(ψ)Ti(ψ)
t =
Vi(ψ). Then the above equation can be rewritten as
k∑
i=1
tr{Vi(ψ̂c)−1Jk} −
k∑
i=1
utiTi(ψ)
tVi(ψ̂c)
−1JkVi(ψ̂c)−1Ti(ψ)ui = 0, k = 1, 2, 3,
and we define ψ∗(U) as the solution of the above equation with respect to ψ. The
solution can be numerically obtained by minimizing the sum of squared values of
three equations with respect to ψ. Moreover, concerning the weight (2), we can use
the numerical derivative given U to compute the partial derivative ∂ψ̂/∂ψt evaluated
at ψ = ψ∗(U). Hence, we can compute the p-value of the LRT of H0 : µ = µ0 from
Algorithm 1.
Using the LRT of H0, the (1−α)% CR of µ can be defined as ECRα = {µ; p(µ) ≥
α}, where p(µ) denotes the p-value of the test statistic Tµ(Y ). Since µ is two-
dimensional in this case, the computing boundary {µ; p(µ) = α} is not straightfor-
ward. The most feasible procedure is to approximate the boundary with a sufficiently
large numbers of points. To this end, we first divide the interval [0, 2pi) by M points
0 = t1 < · · · < tM < 2pi. For each m = 1, . . . ,M , we compute rm satisfying
p(µ̂+ (rm cos tm, rm sin tm)) = α,
which can be carried out via numerical methods (e.g. the bisectional method).
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4.3 Simulation study
We assessed the finite sample performance of the proposed confidence region via
Monte Carlo (MC) algorithm together with the approximate confidence region (7)
by Reitsma and others (2005). When implementing the MC method, we used 500
Monte Carlo samples to compute the p-value. We set µA = 1, µB = −1 and τA =
τB(= τ). We used the between study variances τ
2 of 0.5, 0.75 and 1, and the between
study correlations ρ of 0, 0.4 and 0.8. Following, Jackson and Riley (2014), for each
simulation, two sets of k within-study variances were simulated from a scaled chi-
squared distribution with 1 degree of freedom, multiplied by 0.25, and truncated to
lie within the interval [0.009, 0.6]. We changed the number of studies k over 8,12
and 16, and set the nominal level α to 0.05. In the 1000 simulations, we evaluated
empirical coverage probabilities for 95% confidence regions of the true parameters.
Since the MC method requires unrealistic computational times to calculate boundaries
of a confidence region in large simulations (one such calculation can be implementable
within a reasonable time), we only evaluated coverage rates assessing rejection rates
of the test of null hypothesis for the true parameters. The concrete example of the
confidence region based on the MC method is illustrated in Section 4.4.
The results of the simulations are shown in Table 2. The simulated coverage
probabilities of the standard method, ACR, are seriously smaller than the nominal
level (95%), especially in the case with the small number of studies (k = 8). Such
undesirable results would come from the crude approximation in (7). On the other
hand, the simulated coverage probabilities of the proposed MC method are around
the nominal level in all the scenarios, as expected, which indicates that the proposed
method can produce reasonable confidence region with adequate assessment of the
statistical error of the estimation of (µA, µB).
4.4 Example: screening test accuracy for alcohol problems
Here we provide a re-analysis of the dataset given in Kriston and others (2008), in-
cluding k = 14 studies regarding a short screening test for alcohol problems. Following
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Table 2: Simulated coverage probabilities (%) for 95% confidence regions from the
proposed Monte Carlo (MC) method, and the approximated (ACR) method by Re-
itsma and others (2005).
ρ = 0 ρ = 0.4 ρ = 0.8
k MC ACR MC ACR MC ACR
8 94.2 77.4 94.4 75.9 94.7 75.5
τ2 = 0.5 12 95.3 86.0 94.6 85.4 93.8 82.1
16 94.5 88.1 94.7 88.3 94.4 87.0
8 94.5 78.1 94.1 78.2 94.3 75.9
τ2 = 0.75 12 95.4 87.7 95.5 87.2 94.0 83.3
16 94.6 89.0 94.5 88.3 94.2 88.2
8 95.3 80.6 95.0 80.0 94.3 77.8
τ2 = 1.0 12 95.6 87.9 94.7 87.9 94.3 84.1
16 94.5 89.0 94.2 88.5 95.1 88.7
Reitsma and others (2005), we used logit-transformed values of sensitivity and speci-
ficity, denoted by yAi and yBi, respectively, and associated standard errors sAi and
sBi. For the bivariate summary data, we fitted the bivariate models (5) and (6), and
computed 95% CRs of µ based on the approximated CR of the form (7) given in Re-
itsma and others (2005). Moreover, we computed the proposed CR with 1000 Monte
Carlo samples for calculating p-values of the LRT, and M = 200 evaluation points
that were smoothed by a 7-point moving average for the CR boundary. Following
Reitsma and others (2005), the obtained two CRs of (µA, µB) were transformed to the
scale (logit(µA), 1− logit(µB)), where logit(µA) and 1− logit(µB) are the sensitivity
and false positive rate, respectively. The obtained two CRs are presented in Figure
1 with a plot of the observed data, summary points µ̂, and the summary receiver
operating curve. The approximate CR is smaller than the proposed CR, which may
indicate that the approximation method underestimates the variability of estimating
nuisance variance parameters.
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Figure 1: Approximated and the proposed confidence regions (CRs) and summary
receiver operating characteristics (SROC) curve.
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5 Network Meta-analysis
5.1 Multivariate random-effects model
Suppose there are p treatments in contract to a reference treatment, and let yir be
an estimator of relative treatment effect for the rth treatment in the ith study. We
consider the following multivariate random-effects model:
yi ∼ N(θi, Si), θi ∼ N(β,Σ), i = 1, . . . , k. (8)
where yi = (yi1, . . . , yip)
t, θi = (θi1, . . . , θip)
t is a vector of true treatment effects in
the ith study, β = (β1, . . . , βp)
t is a vector of average treatment effects, and Si is the
within-study variance-covariance matrix. Here we focus on the model (8) known as
the contrast-based model (Salanti and others, 2008; Dias and Ades, 2016), which is
commonly used in practice.
In network meta-analysis, each study contains only pi(< p) treatments (pi usually
ranges from 2 to 5); thereby, several components in yi cannot be defined. When
the corresponding treatments are not involved in the ith study, the corresponding
components in yi and Si are shrunk to the sub-vector and sub-matrix, respectively,
in the model (8). Moreover, when the references treatment is not involved in the ith
study, we can adopt the data argumentation approach of White and others (2012),
in which a quasi-small data set is added to the reference arm, e.g. 0.001 events
for 0.01 patients. To clarify the setting in which yi and Si are shrunk to the sub-
vector and sub-matrix, respectively, we introduce an index aij ∈ {1, . . . , p}, j =
1, . . . , pi, representing the treatment estimates that are available in the ith study,
and define the p-dimensional vector xij of 0’s, excluding the aijth element that is
equal to 1. Moreover, we define Xi = (xi1, . . . , xipi)
t, and yi and Si are the shrunken
pi-dimensional vector and pi × pi matrix of yi and Si, respectively. The model (8)
can be rewritten as
yi ∼ N(Xiθi, Si), θi ∼ N(β,Σ), i = 1, . . . , k. (9)
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Regarding the structure of between study variance Σ, since there are rarely enough
studies to identify the unstructured model of Σ, the compound symmetry structure
Σ = τ2P (0.5) is used in most cases (White, 2015), where P (ρ) is a matrix with all
diagonal elements equal to 1 and all off-diagonal elements equal to ρ.
We define y = (yt1, . . . , y
t
k)
t, X = (Xt1, . . . , X
t
k)
t, Z = diag(X1, . . . , Xk), and
u = (ut1, . . . , u
t
k)
t with ui ∼ N(0, τ2P (0.5)) independently for each i. The hierarchical
model (9) can be expressed as the following random-effects model:
y = Xβ + Zu+ ε, (10)
where ε ∼ N(0, S) with S = diag(S1, . . . , Sk). The unknown parameters in (10) are
β and τ2. The log-likelihood of the model (10) is given by
L(β, τ2) = −1
2
log |V (τ2)| − 1
2
(y −Xβ)tV (τ2)−1(y −Xβ),
where V (τ2) = τ2Z{Ik ⊗P (0.5)}Zt + S and ⊗ denotes the Kronecker product. Note
that y is an N -dimensional vector and N =
∑k
i=1 pi is the total number of compar-
isons.
5.2 Confidence interval of the average treatment effect
In network meta-analysis, we are interested in not only the average treatment effects
β1, . . . , βp in contrast to the reference treatment, but also the treatment differences
βj − βk, j 6= k. To handle these issues in a unified manner, we focus on the linear
combination η = ctβ with known vector c. Define a full-rank p × p matrix A such
that the first element of Aβ is η. The parameter η is equivalent to β1 when we use
XA−1 instead of X in the model (10), so that it is sufficient to consider a confidence
interval of β1.
Define W1 and W2 to be N ×1 and N × (p−1) matrices such that X = (W1,W2),
and ω = (β2, . . . , βp)
t. The model (10) can be rewritten as
y = W1β1 +W2ω + Zu+ ε. (11)
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We first consider testing of H0 : β1 = β10, noting that ω and τ
2 are nuisance param-
eters. The LRT statistics can be defined as
Tβ10(Y ) = min
β1,ω,τ2
L(β1, ω, τ
2)−min
ω,τ2
L(β10, ω, τ
2),
where
L(β1, ω, τ
2) = log |V (τ2)|+ (y −W1β1 −W2ω)tV (τ2)−1(y −W1β1 −W2ω).
Under H0, the constrained maximum likelihood estimator ω̂c and τ̂
2
c satisfy the fol-
lowing equations:
W t2V (τ̂
2
c )
−1r(β10, ω̂c) = 0
tr
{
V (τ̂2c )
−1Q
}− r(β10, ω̂c)tV (τ̂2c )−1QV (τ̂2c )−1r(β10, ω̂c) = 0, (12)
where r(β1, ω) = y−W1β1−W2ω and Q = Z{Ik⊗P (0.5)}Zt. Under H0, it holds that
y = W1β10+W2ω+A(τ
2)u for u ∼ N(0, IN ) and A(τ2) is the Cholesky decomposition
of V (τ2) such that A(τ2)A(τ2)t = V (τ2). The equation (12) can be rewritten as
G1(ω̂c, τ̂
2
c , ω, τ
2, u) ≡W t2V (τ̂2c )−1r(ω, ω̂c, τ2, u) = 0
G2(ω̂c, τ̂
2
c , ω, τ
2, u)
≡ tr{V (τ̂2c )−1Q}− r(ω, ω̂c, τ2, u)tV (τ̂2c )−1QV (τ̂2c )−1r(ω, ω̂c, τ2, u) = 0,
(13)
with r(ω, ω̂c, τ
2, u) = W2(ω − ω̂c) + A(τ2)u. The solution of the first equation
G1(ω̂c, τ̂
2
c , ω, τ
2, u) = 0 with respect to ω is given by
ω∗(u, τ2) = ω̂c − {W t2V (τ̂2c )−1W2}−1W t2V (τ̂2c )−1A(τ2)u.
By replacing w with ω∗(u, τ2) in the second equation in (13), we obtain the following
equation for τ2:
tr
{
V (τ̂2c )
−1Q
}− utA(τ2)tB(τ̂2c )V (τ̂2c )−1QV (τ̂2c )−1B(τ̂2c )A(τ2)u = 0,
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where B(τ2) = IN −W2{W t2V (τ2)−1W2}−1W t2V (τ2)−1, and we define τ2∗ (u) be the
solution of the above equation with respect to τ2. Hence, the solutions of (13) with
respect to ω and τ2 are given by ω∗(u) = ω∗(u, τ2∗ (u)) and τ2∗ (u), respectively. Con-
cerning the weight function w(U), from the implicit function theorem, it follows that
w(U) =
∣∣∣∣det
(
∂G/∂ω̂tc, ∂G/∂τ̂
2
)
det (∂G/∂ωt, ∂G/∂τ2)
∣∣∣∣
ω=ω∗(u),τ2=τ2∗ (u)
,
where G = (Gt1, G2). From (13), we have
∂G1
∂ωt
= −∂G1
∂ω̂tc
= W t2V (τ̂
2
c )
−1W2
∂G2
∂ωt
= −∂G2
∂ω̂tc
= −2W t2V (τ̂2c )−1QV (τ̂2c )−1{W2(ω − ω̂c) +A(τ2)u}.
On the other hand, because derivation of analytical expressions of the partial deriva-
tives with respect to τ2 or τ̂2c requires tedious algebraic calculation, we can use nu-
merical derivatives instead. Therefore, we can carry out Algorithm 1 in Section 2 to
compute the p-value of LRT, and the confidence interval can be obtained as well by
inverting the LRT.
5.3 Simulation study
We investigate the performance of the proposed Monte Carlo (MC) method under
practical network meta-analysis scenarios. We compared the coverage probabilities
of the MC method with those of widely used standard methods: the Wald-type
confidence intervals based on REML estimates, the LR-based confidence interval.
Throughout the experiments, we set the nominal level α to 0.05. Following Noma
and others (2018), we considered a quadrangular network comparing 4 treatments (A,
B, C, and D, regarding A as a reference). The numbers of trials k were set to 8, 12 and
16 and the detailed designs of trials are presented in Supplementary Material. To ap-
proximate practical situations of medical meta-analyses, we mimicked the simulation
settings considered by Sidik and Jonkman (2007). We first generated binomial data
from Xir ∼ Binomial(nir, pir), (i = 1, . . . , k), where r = 0, 1, 2, and 3 corresponds
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to the treatments A, B, C, and D, respectively. The response rate of treatment A,
pi0, was generated from a continuous uniform distribution on [0.095, 0.65] and we set
pir = pi0 exp(θir)/{1 − pi0 + pi0 exp(θir)} for r = 1, 2 and 3, which means that θir is
odds ratio (ORs) to the reference treatment A, i.e. θir = legit(pir)− legit(pi0). Also,
the OR parameters (θi1, θi2, θi3) were generated from a multivariate normal distribu-
tion N(µ, τ2P (0.5)), where µ = (µ1, µ2, µ3) is a vector of the true average treatment
effects set to µ = (0.4, 0.7, 1.0). The sample sizes were set to equal one another,
ni0 = ni1 = ni2 = ni3 for any i and were drawn from a discrete uniform distribution
on 20 and 200. From the generated binomial data Xir’s, we calculated trial-specific
summary statistics yi and Si in the standard manner (Higgins and Green, 2011). In
the 2000 simulations, we evaluated empirical coverage probabilities for 95% confi-
dence intervals of the true parameters. Due to the same computational reason as
noted in Section 4.3, we only evaluated coverage rates of the confidence intervals.
The results of the simulations are shown in Table 3. In general, the coverage prob-
abilities of the REML confidence intervals are sightly better than the LR confidence
intervals. However, they showed undercoverage properties under moderate number
of studies (k = 8, 12) and large heterogeneity (τ = 0.4). On the there hand, the
coverage probabilities of the proposed MC method were generally around the nom-
inal level (95%) in most cases. Under the small number of studies k = 8 and large
heterogeneity (τ = 0.4), the coverage rates were relatively low, but even under these
scenarios, they performed better than the ML and REML methods.
5.4 Example: Schizophrenia data
Adesand and others (2010) carried out a network meta-analysis of antipsychotic med-
ication for prevention of relapse of schizophrenia; this analysis includes k = 15 trials
comparing eight treatments with placebo. In each trial, the outcomes available were
the four outcome states at the end of follow-up: relapse, discontinuation of treatment
due to intolerable side effects and other reasons, not reaching any of the three end-
points, and still in remission. We here considered the last outcome and adopted the
odds ratio as the treatment effect measure.
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Table 3: Simulated coverage probabilities (%) for 95% confidence intervals from the
proposed Monte Carlo (MC) method, REML and LR.
τ = 0.2 τ = 0.3 τ = 0.4
k Methods µ1 µ2 µ3 µ1 µ2 µ3 µ1 µ2 µ3
LR 93.0 92.6 91.8 91.4 90.6 91.1 88.2 88.4 88.6
8 REML 93.7 93.9 92.5 92.6 91.9 92.7 90.4 90.4 90.4
MC 94.2 95.8 94.5 93.4 93.8 93.4 91.3 93.2 92.1
LR 93.5 93.9 92.5 90.2 91.0 91.1 89.8 89.4 90.8
12 REML 94.1 94.6 93.4 91.7 92.0 92.3 91.3 90.6 92.2
MC 95.3 96.1 94.6 93.4 93.8 93.9 92.7 92.7 92.6
LR 93.2 94.4 93.1 92.1 91.6 93.0 90.9 92.3 92.3
16 REML 93.9 95.0 93.7 92.9 92.4 93.5 92.3 92.8 93.2
MC 95.0 95.7 94.5 93.7 94.1 94.2 92.8 94.1 93.9
We set the reference treatment to “Placebo” and applied the multivariate random-
effects model (10). The estimates of between-studies standard deviation τ were 0.28
for the ML and 0.52 for the REML estimation methods, respectively, which shows
that there is substantial heterogeneity between studies. In Table 4 we present the
results of three confidence intervals based on the MC method, the LR-based method
with p-value calculated by the asymptotic distribution, and the REML method. The
number of Monte Carlo samples the MC method was consistently set to 10000. In this
analysis, the confidence intervals of MC were wider than those of LR. On the other
hand, REML produced wider intervals than MC in some treatments whereas REML
produced narrower intervals than MC in the other treatments, which may be due
to the difference between the ML and REML estimates of between study standard
deviation.
6 Discussions
We developed a unified method for constructing confidence intervals of the average
treatment effects in random-effects meta-analysis. The proposed confidence intervals
are based on the LRT, and we proposed a Monte Carlo method to compute its p-
value. In terms of specific applications, we discussed three types of meta-analysis,
univariate meta-analysis, diagnostic meta-analysis, and network meta-analysis, and
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Table 4: Maximum likelihood (ML) and restricted maximum likelihood (REML)
estimates of average treatment effects and confidence intervals from the proposed
Monte Carlo (MC), likelihood ratio (LR) and REML methods in the application to
network-meta analysis of schizophrenia data.
Placebo v.s. ML MC LR REML REML
Olanzapine 4.91 (2.30, 9.27) (2.67, 8.55) 4.52 (2.15, 9.50)
Amisulpride 3.38 (1.30, 8.99) (1.56, 7.30) 3.36 (1.22, 9.31)
Zotepine 2.66 (0.74, 9.29) (0.91, 7.74) 2.66 (0.68, 10.32)
Aripiprazole 2.07 (0.57, 7.70) (0.93, 4.58) 2.07 (0.67, 6.38)
Ziprasidone 5.03 (1.97, 12.38) (2.32, 10.73) 4.90 (1.81, 13.26)
Paliperidone 2.08 (0.61, 7.53) (0.90, 4.81) 2.08 (0.65, 6.67)
Haloperidol 2.65 (1.12, 5.46) (1.26, 5.12) 2.36 (0.94, 5.95)
Risperidone 5.46 (2.12, 13.08) (2.40, 11.82) 5.05 (1.74, 14.64)
demonstrated the usefulness of the proposed method. The R code for implementing
the proposed methods together with applications to three datasets demonstrated in
Sections 3.4, 4.4 and 5.4 are provided in Supplementary Material. The developed
inference method would be adapted to a variety of applications, e.g., the multivariate
individual participant data meta-analysis (Burke and others, 2016). A limitation of
the proposed methods might be rigorous justification of the exactness of the proposed
inference methods. Although the maximum likelihood estimator of the variance pa-
rameters are sufficient statistics in the case that all the within-study variances are the
same, this property might not hold rigorously, under general conditions. Although
there were no theoretical proofs concerning the sufficiency of this estimator under
general conditions, but we could clearly demonstrate the proposed methods could
provide almost exact confidence intervals in the simulation studies.
An alternative way to improve the coverage rates of confidence intervals is using
Bayesian methods (e.g. Sutton and Abrams, 2001). However, results from Bayesian
methods may be sensitive to choices of prior distributions under the realistic number of
studies as discussed in Lambert and others (2005). Also even if we use non-informative
priors, frequentist validity of such Bayesian methods is generally guaranteed under the
large number of samples. Therefore, we need to be careful for using Bayesian methods
sine they do not necessarily work well in terms of accuracy of evidence synthesis.
In addition, the numerical results from our simulations and the illustrative exam-
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ples suggest that statistical methods in the random-effects models should be selected
carefully in practice. Historically, there have been many discrepant results between
meta-analyses and subsequent large randomized clinical trials (LeLorier and others,
1997), and in these cases the meta-analyses have typically tended to provide false
results as in the magnesium example in Section 3.4. Many systematic biases, for ex-
ample, publication bias (Easterbrook and others, 1991) might be important sources
of these discrepancies, but we should also be aware of the risk of providing over-
confident and misleading interpretations caused by the statistical methods based on
large sample approximations. Considering these risks, accurate inference methods
would be preferred in practice. Although there have not been any accurate inference
methods that can be broadly applied in random-effects meta-analyses, our approach
in this article may provide an explicit solution to this relevant problem.
Finally, methodological research on extensions of random-effects meta-analyses to
more complicated statistical models are still in progress (e.g., multivariate network
meta-analyses Riley and others, 2017), and the small sample problems generally exist
in most of these applications. Our methods are applicable to these complicated
models as well as more advanced approaches that might arise in future research. The
developed methods should be effective tools as a unified methodological framework
to obtain accurate solutions in medical evidence synthesis.
7 Software
R code used in this paper is available on github (https://github.com/sshonosuke/mcci-
meta).
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Tables
We provide two tables showing the detailed results in the example of treatment of
suspected acute myocardial infarction in Section 3.4 and the detailed designs of trials
used in the simulation study of network meta-analysis in Section 5.3.
Table S1: Estimates and confidence intervals of the average treatment effect of in-
travenous magnesium on myocardial infarction based on six methods in Section 3.4.
Method Estimate 95% CI
MC 0.449 (0.149, 1.103)
KNHA 0.438 (0.200, 0.956)
DL 0.448 (0.233, 0.861)
LR 0.449 (0.191, 0.903)
REML 0.438 (0.213, 0.895)
PFE 0.471 (0.280, 0.791)
Table S2: Numbers of trials for each study design included in the simulation studies
in Section 5.3.
k = 8 k = 12 k = 16
A vs. B 1 2 2
A vs. C 3 4 6
A vs. D 1 2 3
B vs. C – – 1
B vs. D – 1 1
C vs. D 1 1 1
A vs. C vs. D 1 1 1
B vs. C vs. D 1 1 1
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